BY OUR PLATFORMS
BY THERAPEUTIC AREA
BY THERAPEUTIC AREA
ZeClinics provides preclinical CRO services to evaluate drugs targeting ophthalmic disorders such as diabetic retinopathy, macular degeneration, retinitis pigmentosa, stargardt disease, etc. Our ophthalmic diseases experts are ready to partner with you at the early stages of drug and target discovery, providing innovative zebrafish in vivo models to shorten your product’s time to market.
Zebrafish solutions for accelerating ophthalmic preclinical research.
ZeClinics' preclinical ophthalmic research team has extensive experience, ranging from genetic manipulation, disease model generation, and phenotype-based drug screening. Zebrafish genetic models are customized for an accurate characterization of the biological function of genes. Efficacy and safety screenings are conducted in the most efficient and cost-effective manner.
The zebrafish eye is a suitable paradigm for investigating human ophthalmological disorders. Zebrafish facilitate early developmental studies and single-cell-resolution retinal characterization, while allowing screening of compounds potentially accelerating retinal recovery or protecting from retinal damage.
Zebrafish mirrors human eye pathology better than rodents due to its:
Our preclinical ophthalmic research services are developed to help you addressing:
Generation of custom genetic models of human eye disorders.
Use of genetic models to understand gene biological function in a given condition.
Efficacy and toxicity evaluation in drug discovery.
All these analyzes can be applied to study different ophthalmic indications such as diabetic retinopathy, macular degeneration, retinitis pigmentosa, stargardt disease, etc.
ZeClinics ophthalmic experts have developed a human-relevant model for Dry-Age-related Macular Degeneration (Dry-AMD) studies through light-induced retinal degeneration. This ready-to-use model is well suited for identifying either preventive or therapeutic Dry-AMD treatments.
For efficacy evaluation of compounds with potential capacity to protect from degeneration of retinal photoreceptors.
For efficacy evaluation of compounds with potential capacity to enhance regeneration of photoreceptors in the retina.
Get the milestone data you need to make important decisions in the early stages of drug discovery. Contact us to learn more about ZeClinics’ preclinical ophthalmic research services and how we can help accelerate your R&D process.